Article info
PDFOriginal research
Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis
- Correspondence to Dr Ralph Fingerhut, Swiss Newborn Screening Laboratory, University Children's Hospital Zürich, Zurich, Zürich, Switzerland; ralph.fingerhut{at}synlab.com
Citation
Immunoreactive trypsinogen in healthy newborns and infants with cystic fibrosis
Publication history
- Received November 18, 2021
- Accepted August 25, 2022
- First published September 8, 2022.
Online issue publication
March 15, 2024
Article Versions
- Previous version (17 February 2023).
- Previous version (27 April 2023).
- Previous version (27 April 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.